G132D (p.Gly132Asp) variant of IRS1 (Insulin receptor substrate 1)
G132D (p.Gly132Asp) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
G132D (p.Gly132Asp) variant details
- p.Gly132Asp
- NCI-TCGA Cosmic COSV5934
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.